under the radar re Optiobiotix13 Nov 2015 11:59
Venture Life announces it has signed a letter of intent to enter a strategic development and commercial alliance with Otiobiotix a life science business developing compounds to tackle obesity, high cholesterol and diabetes. This would be developed by Venture Life into products in the form of registered food supplements and over the counter products.
With contracts recently signed with China and India i think that the company is in for a profitable year ahead and has laid the foundations to increase there sales significantly. With the high profile that the shares in Optiobiotix has had over the last week it will only add in my opinion to the value of this company in time.
The above agreement was signed on the 9th June 2015 via RNS notification
Major shareholders are as follows:-
Mr Gianluca Barbuti 20.2%
Jo Hambros Capital Management 11.63%
Mr Jerry Randall 11,00%
Aviva PLC 9.95%
Dir Michael Flynn 8.4%
Mr Andrew Sinclair 6.2%
Quilter Cheviot 5.4%
Mr Anthony Ahearne 4.9%
Ms Sharon Collins 4.0%
The board of directors all come with a good pedigree looking through their previous posts.
Anyone looking for a long term investment with very little risk could well be rewarded IMO